FREMONT, CA, USA, December 8, 2020 /EINPresswire.com/ — PrinterPrezz, Inc., a trailblazer in combining polymer and metal 3D printing, nanotechnologies and surgical expertise to design and manufacture next generation medical devices, today announced completion of a $16 million Series A financing round which includes $9 million of new money. D. One Vision Management through its DOV Singularity Fund served as the largest financial investor and co-lead, Boutique Venture Partners served as the investment syndicate organizer and co-lead, Berkeley Catalyst Fund served as co-lead investor, and Solvay Ventures as strategic investor.
The funding will be utilized to expand PrinterPrezz’s engineering teams and to ramp development efforts in specialized materials and technologies to improve medical device innovation.
Shri Shetty, CEO of PrinterPrezz, commented, “PrinterPrezz has robust additive manufacturing technology platforms for developing next generation medical devices both with metals and polymers. We also have a platform to extend our regulatory pathway experience. PrinterPrezz continues to offer opportunities for innovative medical device companies to leverage our infrastructure and know-how to speed their time-to-market.
We believe that the future of medical device development is in the joining of novel materials with proprietary technology,” continued Shetty. “PrinterPrezz continues to build partnerships to develop these processes. This investment validates our model and secures our opportunity to explore nanotechnology and other applications for truly life changing innovations. I am grateful to our investors, employees and customers for their support and commitment.”